Milestone Pharmaceuticals Inc [MIST] stock is trading at $1.93, up 1.05%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The MIST shares have gain 7.22% over the last week, with a monthly amount drifted -5.85%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Milestone Pharmaceuticals Inc [NASDAQ: MIST] stock has seen the most recent analyst activity on September 11, 2025, when Wells Fargo initiated its Overweight rating and assigned the stock a price target of $4. On August 22, 2024, Rodman & Renshaw initiated with a Buy rating and assigned a price target of $9 on the stock. Jefferies downgraded its rating to a Hold and decreased its price target to $4 on June 20, 2023. Piper Sandler upgraded its rating to a Overweight and raised its price target to $10 on April 22, 2022. H.C. Wainwright started tracking with a Buy rating for this stock on March 05, 2021, and assigned it a price target of $20. In a note dated July 29, 2020, Oppenheimer upgraded an Outperform rating on this stock but restated the target price of $18.
Milestone Pharmaceuticals Inc [MIST] stock has fluctuated between $0.63 and $2.75 over the past year. Currently, Wall Street analysts expect the stock to reach $10 within the next 12 months. Milestone Pharmaceuticals Inc [NASDAQ: MIST] shares were valued at $1.93 at the most recent close of the market. An investor can expect a potential return of 418.13% based on the average MIST price forecast.
Analyzing the MIST fundamentals
Gross Profit Margin for this corporation currently stands at -0.01% with Operating Profit Margin at -530.78%, Pretax Profit Margin comes in at -428.22%, and Net Profit Margin reading is -426.76%. To continue investigating profitability, this company’s Return on Assets is posted at -0.53, Equity is -18.85 and Total Capital is -0.74. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of2.79.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.8597 points at the first support level, and at 1.7893 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.9952, and for the 2nd resistance point, it is at 2.0603.
Ratios To Look Out For
For context, Milestone Pharmaceuticals Inc’s Current Ratio is 4.97. Also, the Quick Ratio is 4.97, while the Cash Ratio stands at 4.44.
